Srx Health Solutions, Inc. · AMEX:SRXH
Srx Health Solutions — Investor Presentation (May 2025)
17 slides from Srx Health Solutions's investor presentation, May 7, 2025
Slide 1: SRx Corporate Presentation
SRx Corporate Presentation May 2025 SR. HEALTH : ; SOLUTIONS Making Healthcare Simple
Slide 2: Forward Looking Statements
Forward Looking Statements The information in this presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contain
Slide 3: Leadership Team
Leadership Team Michael Young Director Michael Young serves as a director of SRx Health Solutions. Prior to SRx, Michael served as Chairman of Better Choice Company, which subsequently merged with SRx. Additionally, Michael is the founding partner of Cottingham Capital. Michael has extensive senior
Slide 4: A Lifelong Mission to Provide Quality Patient Care
A Lifelong Mission to Provide Quality Patient Care “After years in retail pharmacy, | felt that the system was broken and needed to create a more patient-centric approach to support patients with chronic diseases.” Adesh Vora, Pharm. D. Founder & Executive Chairman SRx’s Start National Expansion SRx
Slide 5: SRx At a Glance
SRx At a Glance What Are Specialty 3 4 2 0) Pharmacies? Specialty Health Specialty Pharmacies Clinics Specialty pharmacies service patients with chronic diseases ~$145M Revenue : For the nine months Z Deliver care and support that ended 6/30/2024 retail pharmacies cannot provide 4 40 0) oe Clinical
Slide 6: Creating a North American Network
Creating a North American Network 3 es 6 * yA aa ws ay a> ae oD oy Ok «, (Hybrid Locations) | 1. A second warehouse was purchased in Calgary, Alberta in March 2024 and it is projected to be operational in Fis The SRx Network extends across Canada, making it one of the most accessible providers of sp
Slide 7: SRx Ecosystem of Specialty Healthcare Services
SRx Ecosystem of Specialty Healthcare Services SRx’s specialty pharmacies serve as the foundation to the Company’s integrated network All-Inclusive Specialty Pharmacies Partner Engagement 20 pharmacies across Canada, providing Biologic Care Coordinators and Nurse Case personalized services. Capable
Slide 8: Complex Patient Care Ecosystem
Complex Patient Care Ecosystem The SRx network represents a critical link in facilitating specialty care Partner Physician Referral & Patient referred to SRx for specialty Patient Onboarding therapeutic treatment e008 Introductory call, counseling, pre- O screening and other administrative requireme
Slide 9: Strong Industry Tailwinds
Strong Industry Tailwinds Growing Prevalence of Chronic Disease in Seniors Of Canadians aged 65+ report having at least 1 chronic disease 73% U K. Of Canadians aged 65+ report having 2 or more chronic diseases 33% Of Canadians aged 60+ take 3 or more prescription medications® 52% int 1. Public Healt
Slide 10: Focus on Partnerships
Focus on Partnerships © © Continued YoY Same Store Pharmacy Growth Physician Partnerships Continued Continued ¢ same store @ relationships pharmacy YoY with providers to growth of 8% deliver the best care possible Patient Support Programs Developing @ comprehensive care programs with new and innovat
Slide 11: Strategic Growth
Strategic Growth About Choice Specialty Pharmacy Growth Strategy Choice Specialty Pharmacy is a fully licensed Strengthens SRx’s specialty pharmacy provider of specialized pharmacy services in the footprint in the U.S., complementing U.S., dedicated to delivering efficient, existing operations in Ca
Slide 12: Pro Forma Capitalization Table
Pro Forma Capitalization Table Pro Forma Including Shares issued to SRx Health Solutions Shares Outstanding" r 35,233,010 Options (WAEP: $105.44) 99,400 = Fully Diluted Shares Outstan Ownership 35,601,755 ooo * Insiders Non-Affiliates (1) As of April 24, 2025, includes 19.7M exchangeable shares, and
Slide 13: Investment Highlights
Investment Highlights Strong Industry Tailwinds 6 Of Canadians aged 65+ 73% B® report having at least 1 chronic disease 5 million Canadians are without access to a primary healthcare provider US specialty drug spend, ~$410B representing approx. 51% of total 2024 US drug purchases US specialty drug s
Slide 14: SRx Health Solutions
HEALTH SOLUTIONS
Slide 15: Appendix
APPENDIX
Slide 16: Halo Overview
Bre HALO OVERVIEW Packed with nutrients. Minimally processed . Rich in flavor. For pet parents seeking all the Rooted in Nature b f a raw diet with the ease and ! ce of freeze-dried raw food or snacks and treats : SS Targeting most attractive consumer : segments Domed euepe cocaine a Significant Onl
Slide 17: Pro Forma Combined Debt Overview
Pro Forma Combined Debt Overview (As of September 30, 2024) Debt (USD millions) % Total Coupon PIK or Cash Interest_ Maturity Term Loan $33.9 86% 8.8% Cash Interest 2027 - In Forbearance Bank Indebtedness $3.6 9% Prime + 2.25% Cash Interest 2027 Wintrust Receivables Credit Facility $1.9 5% Prime + 2
SRx Health Solutions — Investor Presentation (May 2025) on 6ix